Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 14.15 Delayed Data As of Nov 30 |  -0.005 / -0.04%Today’s Change | 13.19 Today|||52-Week Range 17.15 | -9.33% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Revenue and Income | Net Revenues | 15.1B | 16.0B | 16.0B | 18.9B | |
| Cost of Goods Sold | 3.9B | 4.6B | 4.0B | 5.2B | ||
| Depreciation And Amortization | 1.5B | 1.6B | 1.6B | 2.5B | ||
| Operating Expenses | Gross Income | 9.7B | 9.8B | 10.4B | 11.2B | |
| General Expenses | 8.3B | 8.6B | 8.6B | 9.6B | ||
| Other Operating Expenses | -53.2M | -- | 0.00 | 0.00 | ||
| Research And Development | 2.9B | 2.9B | 2.9B | 3.3B | ||
| Total Operating Expenses | 13.6B | 14.8B | 14.2B | 17.3B | ||
| Non-Operating Expenses | Operating Income | 1.5B | 1.2B | 1.8B | 1.6B | |
| Extraordinary Credit | 118.2M | 170.3M | 35.9M | 53.8M | ||
| Extraordinary Charge | -492.8M | -1.1B | -1.1B | -1.2B | ||
| Pre-Tax Equity Earnings | -25.0K | -14.3M | -290.5M | -393.4M | ||
| Interest Expense On Debt | 66.3M | 69.8M | 114.9M | 614.8M | ||
| Other Expenses | -38.4M | 1.1B | 1.6B | 1.3B | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 1.0B | 1.3B | 2.0B | 855.7M | |
| Income Taxes | -308.7M | -257.0M | -275.2M | -127.3M | ||
| Minority Interest | -27.6M | -5.3M | -1.6M | -1.0M | ||
| Net Income | 667.8M | 1.1B | 1.7B | 984.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.6B | 1.6B | 1.6B | 1.9B | |
| Shares To Calculate EPS Diluted | 1.6B | 1.6B | 1.6B | 1.9B | ||
| Earnings Per Share | EPS | $0.43 | $0.68 | $1.08 | $0.51 | |
| EPS Diluted | $0.42 | $0.68 | $1.07 | $0.51 | ||
